Publication | Open Access

Treatment with Non-specific HDAC Inhibitors Administered after Disease Onset does not Delay Evolution in a Mouse Model of Progressive Multiple Sclerosis

Neurodegenerative DiseasesAutoimmune DiseaseDisease ProgressionDelay EvolutionNovel TherapyImmunologyProgressive Multiple SclerosisNeurologyNeuroscienceMultiple SclerosisMedicineMouse Model